The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 01, 2020
Filed:
Aug. 05, 2016
Applicant:
Ube Industries, Ltd., Ube-shi, Yamaguchi, JP;
Inventors:
Ken-ichi Komori, Ube, JP;
Akishi Ninomiya, Ube, JP;
Shigeru Ushiyama, Ube, JP;
Masaru Shinohara, Ube, JP;
Koji Ito, Ube, JP;
Tetsuo Kawaguchi, Ube, JP;
Yasunori Tokunaga, Ube, JP;
Hiroyoshi Kawada, Ube, JP;
Haruka Yamada, Ube, JP;
Yusuke Shiraishi, Ube, JP;
Masahiro Kojima, Ube, JP;
Masaaki Ito, Ube, JP;
Tomio Kimura, Tokyo, JP;
Assignee:
UBE INDUSTRIES, LTD., Ube-Shi, Yamaguchi, JP;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 403/04 (2006.01); C07D 401/04 (2006.01); A61K 31/4427 (2006.01); A61K 31/506 (2006.01); C07D 401/14 (2006.01); C07D 405/14 (2006.01); C07D 413/14 (2006.01); C07F 7/18 (2006.01); A61K 31/695 (2006.01); A61K 31/4433 (2006.01); A61K 31/5377 (2006.01); A61K 31/443 (2006.01); C07C 55/10 (2006.01); C07C 57/145 (2006.01); C07C 59/255 (2006.01); C07D 403/14 (2006.01); C07F 7/08 (2006.01);
U.S. Cl.
CPC ...
C07D 403/04 (2013.01); A61K 31/443 (2013.01); A61K 31/4427 (2013.01); A61K 31/4433 (2013.01); A61K 31/506 (2013.01); A61K 31/5377 (2013.01); A61K 31/695 (2013.01); C07C 55/10 (2013.01); C07C 57/145 (2013.01); C07C 59/255 (2013.01); C07D 401/04 (2013.01); C07D 401/14 (2013.01); C07D 403/14 (2013.01); C07D 405/14 (2013.01); C07D 413/14 (2013.01); C07F 7/0892 (2013.01); C07F 7/18 (2013.01); Y02P 20/55 (2015.11);
Abstract
The present invention provides a compound of general formula (I) (wherein, R, X, p and q are as described in the present description and claims), or a pharmacologically acceptable salt thereof, and a pharmaceutical composition containing that compound.